The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 …

P Van Damme, I De Coster, AS Bandyopadhyay… - The Lancet, 2019 - thelancet.com
Background Use of oral live-attenuated polio vaccines (OPV), and injected inactivated polio
vaccines (IPV) has almost achieved global eradication of wild polio viruses. To address the …

Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis

A Ciapponi, A Bardach, LR Ares… - Cochrane Database …, 2019 - cochranelibrary.com
Background Poliomyelitis mainly affects unvaccinated children under five years of age,
causing irreversible paralysis or even death. The oral polio vaccine (OPV) contains live …

Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden

EB Brickley, RI Connor, WF Wieland-Alter… - BMJ global …, 2019 - gh.bmj.com
Background Our understanding of the acquisition of intestinal mucosal immunity and the
control of poliovirus replication and transmission in later life is still emerging. Methods As …

Safety and immunogenicity of Sabin strain inactivated poliovirus vaccine compared with salk Strain Inactivated poliovirus vaccine, in different sequential schedules …

Y Hu, K Xu, W Han, K Chu, D Jiang… - Open Forum …, 2019 - academic.oup.com
Background A new Sabin strain inactivated poliovirus vaccine (sIPV) proved to be
immunogenic and safe in all IPV primary immunization in the previous study, with the …

Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis

N Jaiswal, S Singh, A Agarwal… - Cochrane Database …, 2019 - cochranelibrary.com
Background Poliomyelitis is a debilitating and deadly infection. Despite exponential growth
in medical science, there is still no cure for the disease, which is caused by three types of …

[HTML][HTML] Sabin 株脊髓灰质炎灭活疫苗与不同剂型Ⅰ 型Ⅲ 型脊髓灰质炎减毒活疫苗序贯接种的抗体滴度比较

赵志梅, 黄腾, 李国良, 杨晓蕾, 蒋蕊鞠, 叶慧… - 中华疾病控制 …, 2019 - zhjbkz.ahmu.edu.cn
赵志梅, 黄腾, 李国良, 杨晓蕾, 蒋蕊鞠, 叶慧, 赵婷, 李菁, 刘小畅, 傅宇婷, 施红媛, 周海军, 莫兆军,
车艳春, 杨净思. Sabin 株脊髓灰质炎灭活疫苗与不同剂型Ⅰ 型Ⅲ 型脊髓灰质炎减毒活疫苗序贯 …

[HTML][HTML] Remarks on the possibility of introducing the fractionated dose of the inactivated poliomyelitis vaccine in the Latin American Child Immunization Schedule

A Arbo, LH Falleiros-Arlant, EL López… - Revista chilena de …, 2019 - SciELO Chile
Given that the last notified case of poliomyelitis due to wild poliovirus type 2 was in 1999, in
2012, the Strategic Advisory Group of Experts on Immunization (SAGE) of the World Health …

[HTML][HTML] Comparing the antibody titers of sequential program of Sabin strain-based inactivated poliovirus vaccine followed by bivalent types 1 and 3 oral poliovirus …

Z Zhi-mei, H Teng, LI Guo-liang, Y Xiao-lei… - 中华疾病控制 …, 2019 - zhjbkz.ahmu.edu.cn
Objective To evaluate the antibody titer distributions after primary vaccination by different
sequential schedules of Sabin strain-based inactivated poliovirus vaccine (sIPV) and …

[PDF][PDF] A systematic review and meta-analysis of fractional dose compared to standard dose inactivated polio vaccination in children

TR Mashunye - 2019 - open.uct.ac.za
Abstract The World Health Organisation (WHO) recommends the introduction of at least one
single dose of inactivated polio vaccine (IPV) in routine immunisation schedules to mitigate …

[引用][C] 脊髓灰质炎免疫策略调整进程中不同免疫程序接种效果的比较

傅宇婷, 黄腾, 英志芳, 车艳春, 杨晓蕾, 李国良, 姜莉… - 中国生物制品学杂志, 2019